Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry

被引：0
|
作者：
Jamie L. Todd
Megan L. Neely
Robert Overton
Katey Durham
Mridu Gulati
Howard Huang
Jesse Roman
L. Kristin Newby
Kevin R. Flaherty
Richard Vinisko
Yi Liu
Janine Roy
Ramona Schmid
Benjamin Strobel
Christian Hesslinger
Thomas B. Leonard
Imre Noth
John A. Belperio
Scott M. Palmer
机构：
[1] Duke Clinical Research Institute,Division of Pulmonary and Critical Care Medicine
[2] Duke University Medical Center,undefined
[3] Boehringer Ingelheim Pharmaceuticals Inc.,undefined
[4] Yale School of Medicine,undefined
[5] Houston Methodist Hospital,undefined
[6] Jane and Leonard Korman Respiratory Institute,undefined
[7] Duke Clinical & Translational Science Institute,undefined
[8] University of Michigan,undefined
[9] Staburo GmbH,undefined
[10] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
[11] University of Virginia,undefined
[12] David Geffen School of Medicine at UCLA,undefined
来源：
Respiratory Research | / 20卷
关键词：
Interstitial lung diseases; Observational study; Proteome; Registries;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
    Jamie L. Todd
    Richard Vinisko
    Yi Liu
    Megan L. Neely
    Robert Overton
    Kevin R. Flaherty
    Imre Noth
    L. Kristin Newby
    Joseph A. Lasky
    Mitchell A. Olman
    Christian Hesslinger
    Thomas B. Leonard
    Scott M. Palmer
    John A. Belperio
    BMC Pulmonary Medicine, 20
  • [42] Long-term Air Pollution Exposure Is Associated With Increased Severity of Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry
    Sack, C.
    Wojdyla, D.
    Macmurdo, M. G.
    Gassett, A.
    Kaufman, J. D.
    Raghu, G.
    Redlich, C. A.
    Li, P.
    Olson, A. L.
    Leonard, T. B.
    Todd, J. L.
    Neely, M. L.
    Snyder, L. D.
    Gulati, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis A Cross-Sectional Analysis of the IPF-PRO Registry
    O'Brien, Emily C.
    Hellkamp, Anne S.
    Neely, Megan L.
    Swaminathan, Aparna
    Bender, Shaun
    Snyder, Laurie D.
    Culver, Daniel A.
    Conoscenti, Craig S.
    Todd, Jamie L.
    Palmer, Scott M.
    Leonard, Thomas B.
    CHEST, 2020, 157 (05) : 1188 - 1198
  • [44] Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
    Todd, Jamie L.
    Vinisko, Richard
    Liu, Yi
    Neely, Megan L.
    Overton, Robert
    Flaherty, Kevin R.
    Noth, Imre
    Newby, L. Kristin
    Lasky, Joseph A.
    Olman, Mitchell A.
    Hesslinger, Christian
    Leonard, Thomas B.
    Palmer, Scott M.
    Belperio, John A.
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [45] Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
    Joao A. de Andrade
    Tejaswini Kulkarni
    Megan L. Neely
    Anne S. Hellkamp
    Amy Hajari Case
    Daniel A. Culver
    Kalpalatha Guntupalli
    Shaun Bender
    Craig S. Conoscenti
    Laurie D. Snyder
    Respiratory Research, 23
  • [46] Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
    de Andrade, Joao A.
    Kulkarni, Tejaswini
    Neely, Megan L.
    Hellkamp, Anne S.
    Case, Amy Hajari
    Culver, Daniel A.
    Guntupalli, Kalpalatha
    Bender, Shaun
    Conoscenti, Craig S.
    Snyder, Laurie D.
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [47] Peripheral blood biomarkers in idiopathic pulmonary fibrosis
    Vij, Rekha
    Noth, Imre
    TRANSLATIONAL RESEARCH, 2012, 159 (04) : 218 - 227
  • [48] Peripheral Blood Biomarkers Differentiate Extent Of Dlco (but Not FVC) Changes For Idiopathic Pulmonary Fibrosis (IPF)
    Steele, M. P.
    Luna, L.
    Yang, I. V.
    Cotter, J.
    Talbert, J.
    Leach, S.
    Kidd, R.
    Turner, J.
    Kummer, N.
    Boon, K.
    Brown, K. K.
    Schwarz, M. I.
    Schwartz, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [49] Circulating Urokinase-Type Plasminogen Activator Receptor Protein Highly Correlates With the Severity of Idiopathic Pulmonary Fibrosis (IPF): Data From the IPF-PRO Registry
    Todd, J. L.
    Mulder, H.
    Neely, M. L.
    Belperio, J. A.
    Lasky, J. A.
    Luckhardt, T. R.
    Palmer, S. M.
    Hesslinger, C.
    Schlange, T.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [50] Exploring Relationships Between Resources and Practices of ILD Centers and Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
    De Andrade, J. A.
    Kulkarni, T.
    Neely, M. L.
    Hellkamp, A. S.
    Case, A. Hajari
    Culver, D. A.
    Guntupalli, K.
    Bender, S.
    Conoscenti, C. S.
    Snyder, L. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345